TRZPatide-GLP- NEW

$199.00

Ideal for chronic weight management, and obesity‑related conditions. It activates both GLP‑1 and GIP receptors to improve insulin release, reduce appetite, and support significant weight loss. It is self-administered as a subcutaneous (under the skin) and should always be used together with diet and exercise.

Ideal for chronic weight management, and obesity‑related conditions. It activates both GLP‑1 and GIP receptors to improve insulin release, reduce appetite, and support significant weight loss. It is self-administered as a subcutaneous (under the skin) and should always be used together with diet and exercise.